title: Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.
abstract: Analogs of A-98593 (1) and its enantiomer ABT-594 (2) with diverse substituents on the pyridine ring were prepared and tested for affinity to nicotinic acetylcholine receptor binding sites in rat brain and for analgesic activity in the mouse hot plate assay. Numerous types of modifications were consistent with high affinity for [3H]cytisine binding sites. By contrast, only selected modifications resulted in retention of analgesic potency in the same range as 1 and 2. Analogs of 2 with one or two methyl substituents at the 3-position of the azetidine ring also were prepared and found to be substantially less active in both assays.
authors.affiliation: Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, IL 60064-3500, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Holladay
authors.forename: H
authors.initials: H
authors.lastname: Bai
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: N H
authors.initials: NH
authors.lastname: Lin
authors.forename: J F
authors.initials: JF
authors.lastname: Daanen
authors.forename: K B
authors.initials: KB
authors.lastname: Ryther
authors.forename: J T
authors.initials: JT
authors.lastname: Wasicak
authors.forename: J F
authors.initials: JF
authors.lastname: Kincaid
authors.forename: Y
authors.initials: Y
authors.lastname: He
authors.forename: A M
authors.initials: AM
authors.lastname: Hettinger
authors.forename: P
authors.initials: P
authors.lastname: Huang
authors.forename: D J
authors.initials: DJ
authors.lastname: Anderson
authors.forename: A W
authors.initials: AW
authors.lastname: Bannon
authors.forename: M J
authors.initials: MJ
authors.lastname: Buckley
authors.forename: J E
authors.initials: JE
authors.lastname: Campbell
authors.forename: D L
authors.initials: DL
authors.lastname: Donnelly-Roberts
authors.forename: K L
authors.initials: KL
authors.lastname: Gunther
authors.forename: D J
authors.initials: DJ
authors.lastname: Kim
authors.forename: T A
authors.initials: TA
authors.lastname: Kuntzweiler
authors.forename: J P
authors.initials: JP
authors.lastname: Sullivan
authors.forename: M W
authors.initials: MW
authors.lastname: Decker
authors.forename: S P
authors.initials: SP
authors.lastname: Arneric
mesh_terms: D000470:Alkaloids / Q000378:metabolism; D018712:Analgesics, Non-Narcotic / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001384:Azetidines / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D001392:Azocines; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D051379:Mice; D018722:Nicotinic Agonists / Q000737:chemistry / Q000494:pharmacology*; D010147:Pain Measurement / Q000187:drug effects; D011725:Pyridines / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011807:Quinolizines; D051381:Rats; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014316:Tritium; D000093843:Quinolizidine Alkaloids
chemical_list: D000470:Alkaloids; D018712:Analgesics, Non-Narcotic; D001384:Azetidines; D001392:Azocines; D018722:Nicotinic Agonists; D011725:Pyridines; D011807:Quinolizines; D011978:Receptors, Nicotinic; D014316:Tritium; C109763:5-(2-azetidinylmethoxy)-2-chloropyridine; C004712:cytisine; D000093843:Quinolizidine Alkaloids